Drug · DIN 02296411
TRIDURAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 9, 2026; first marketed August 14, 2007.
- Drug Identification Number (DIN)
- 02296411
- Company (DIN owner)
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Tramadol N02AX02
- Class
- Human
- Record last updated
- March 11, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRAMADOL HYDROCHLORIDE | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 9, 2026: NOC 37065New Drug Submission (NDS) · Administrative: Change in product ownership
- February 19, 2025: NOC 34871New Drug Submission (NDS)
- January 10, 2013: NOC 14016New Drug Submission (NDS) · Manufacturer name change
- August 2, 2007: NOC 8958Supplement to a New Drug Submission (SNDS) · Product name change
- June 15, 2007: NOC 8846New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “tridural”. A notice may cover another product or only some lots: read it to see what it covers.
- Tridural (tramadol HCl extended release tablets) - Removal of Tablet Markings in Certain LotsOctober 26, 2015 · Drugs · Product safety
Other DINs named TRIDURAL
- DIN 02296381 · Marketed
- DIN 02296403 · Marketed